3-Methyl-5-(4-trifluoromethyl-phenyl)-isoxazole-4-carboxylic acid methyl ester, 95.0%, 1g

(4-Methoxy-3,5-dimethylpyridin-2-yl)methanol, 97.0%, 5g

EDTA-Manganese disodium salt x 2H2O, min. 93%, for synthesis, 500 g, plastic packaging.

2-(4,5-Difluoro-2-nitrophenyl)acetic acid, 95.0%, 100mg

5-(3-Hydroxy-3-methyl-but-1-ynyl)-thiophene-2-carboxylic acid, 95.0%, 1g

3-Bromo-6-chloro-1-tetrahydropyran-2-yl-pyrazolo[4,3-c]pyridine, 98%, 500mg

2-[(4-methoxybenzyl)amino]ethanol hydrochloride, 95.0%, 1g

RiboFlow® E. coli

5,7-Difluoro-1-benzofuran-3-carboxylic acid, 95%, 1g

1-(3-Bromopropyl)-4-fluorobenzene, 95.0%, 1g

Methyl 2-bromo-4-fluoro-5-methylbenzoate, 98%, 1g

Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-(3-iodo-4-methoxyphenyl)propanoate, 95+%, 500mg

3-Ethyl-5-fluoro-1H-indole, 1g